Dyadic International (DYAI)

$DYAI Supportive monetary policy

$DYAI Strong earnings outlook

JAGU✅ uranium+rare earth play, Keep this high on watch for next week. JAGU sits right in the middle of: •⚛️ Energy crisis (uranium) •🛰️ Defense tech (rare earths) •🌍 Geopolitical supply shift -The world is entering a resource war and most people still don’t see it Critical minerals uranium and rare earths are now essential for defense energy AI and every advanced system the future depend -Uranium and rare earths are needed in the war and in all things needed in the future, and the US will be flooding billions into South America, exactly where jaguar is.JAGU sitting right where the money is going. US pushing billions into critical minerals in Latin America Argentina becoming a key supply hub And JAGU already has exposure there… Rare earth + uranium + IPO reset = serious setup. $SUNE $YHC $NKLR $DYAI nice list /.

$DYAI RSI: 52.55, MACD: -0.0132 Vol: 0.02, MA20: 0.79, MA50: 0.84 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

$DYAI Here is the link PR to the presentation https://seekingalpha.com/pr/20436701-life-sciences-virtual-investor-forum-presentations-now-available-for-online-viewing

$DYAI https://seekingalpha.com/pr/20438093-dyadic-applied-biosolutions-announces-commercial-distribution-partnership-with-ibt

$DYAI 07:22 on Mar. 16 2026 Dyadic Applied BioSolutions Enters Into Original Equipment Manufacturer Distribution Agreement With Integrated Biotherapeutics To Expand Protein Product Reach #tradeideas

$DYAI Listen to the presentation, they have a lot of products hitting the market, and more to come in 2027, 2028. Revenue coming. Market under-estimating now.

The B2i Digital team is pleased to announce that Dyadic Applied BioSolutions (Nasdaq: $DYAI) is participating in the Life Sciences Virtual Investor Forum, co-hosted by Virtual Investor Conferences and Zacks Small Cap Research, on Thursday, March 12, 2026, at 1:30 PM EDT. The Life Sciences Virtual Investor Forum is a B2i Digital Featured Conference. For more details, please visit: https://b2idigital.com/otc-life-sciences-virtual-investor-forum Virtual Investor Conferences brings together public companies and a global audience of retail and institutional investors for live executive presentations, Q&A sessions, and on-demand replays. The platform is open to public companies listed on NYSE, Nasdaq, TSX, CSE, ASX, and the OTC Markets. Dyadic is a global biotechnology company focused on the scalable production of high-value, precision-engineered functional input proteins for use in life sciences, food and nutrition, and industrial biotechnology applications. Presenting on behalf of Dyadic will be Joe Hazelton, President and Chief Operating Officer. Mr. Hazelton joined Dyadic in 2021 as Chief Business Officer and was promoted to his current role in 2024, bringing more than two decades of leadership in biotech commercialization with experience at both Dyadic and Novartis. To register for this presentation, visit: https://www.virtualinvestorconferences.com/wcc/eh/4814904/lp/5262339/dyadic-international-nasdaq-dyai?utm_source=b2i&utm_medium=marketing&utm_campaign=0326LifeSciencesVIC For more information about Dyadic International, visit: https://dyadic.com/investors/overview/ Content about any specific company was provided and approved by that company or is available in the public domain. B2i Digital, Inc. has not independently verified the accuracy of the information contained herein. The content contained herein is informational only, and no content contained herein shall be considered an offer to solicit the sale of any security or make a recommendation to purchase a security. B2i Digital is not a broker-dealer or investment adviser.

$DYAI ALERT – FIRST COMMERCIAL - BREAKOUTS..RUNNERS AND HOT PENNIES https://investorshangout.com/post/view?id=6819130